Ingeborg Winge

658 total citations
17 papers, 364 citations indexed

About

Ingeborg Winge is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Ingeborg Winge has authored 17 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Psychiatry and Mental health. Recurrent topics in Ingeborg Winge's work include Tryptophan and brain disorders (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Ingeborg Winge is often cited by papers focused on Tryptophan and brain disorders (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Ingeborg Winge collaborates with scholars based in Norway, Sweden and Finland. Ingeborg Winge's co-authors include Jan Haavik, Jeffrey A. McKinney, Per M. Knappskog, Rune Kleppe, Stefan Johansson, Ming Ying, Anne Halmøy, P.M. Knappskog, Clive S. D’Santos and Oriol Bachs and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Ingeborg Winge

16 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingeborg Winge Norway 11 185 72 63 51 49 17 364
Stefanie Schuster Germany 10 193 1.0× 77 1.1× 49 0.8× 29 0.6× 22 0.4× 16 424
Norell M. Hadzimichalis United States 7 126 0.7× 116 1.6× 17 0.3× 47 0.9× 42 0.9× 8 314
Yasuko Hisano Japan 12 281 1.5× 75 1.0× 14 0.2× 47 0.9× 39 0.8× 17 454
Laila Cigana Schenkel Brazil 9 130 0.7× 74 1.0× 55 0.9× 49 1.0× 14 0.3× 9 315
S.P. Craig United Kingdom 11 185 1.0× 114 1.6× 67 1.1× 39 0.8× 37 0.8× 13 431
Junko Kawai Japan 6 155 0.8× 60 0.8× 31 0.5× 37 0.7× 93 1.9× 11 351
Adriana Ramos United States 14 393 2.1× 44 0.6× 20 0.3× 93 1.8× 37 0.8× 17 569
Chul Lee South Korea 13 112 0.6× 59 0.8× 75 1.2× 16 0.3× 18 0.4× 27 388
Madhabi Barua United States 9 169 0.9× 51 0.7× 24 0.4× 93 1.8× 119 2.4× 16 510
Micah Simmons United States 14 282 1.5× 199 2.8× 34 0.5× 65 1.3× 48 1.0× 20 499

Countries citing papers authored by Ingeborg Winge

Since Specialization
Citations

This map shows the geographic impact of Ingeborg Winge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingeborg Winge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingeborg Winge more than expected).

Fields of papers citing papers by Ingeborg Winge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingeborg Winge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingeborg Winge. The network helps show where Ingeborg Winge may publish in the future.

Co-authorship network of co-authors of Ingeborg Winge

This figure shows the co-authorship network connecting the top 25 collaborators of Ingeborg Winge. A scholar is included among the top collaborators of Ingeborg Winge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingeborg Winge. Ingeborg Winge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Aas, Turid, Ingeborg Winge, Karin Collett, et al.. (2025). Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer. The Journal of Pathology Clinical Research. 11(6). e70050–e70050.
2.
Winge, Ingeborg, Karen Toska, May Britt Kalvenes, et al.. (2024). Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features. Breast Cancer Research. 26(1). 126–126. 3 indexed citations
3.
Finne, Kenneth, Ingeborg Winge, Jarle B. Arnes, et al.. (2024). Global and single-cell proteomics view of the co-evolution between neural progenitors and breast cancer cells in a co-culture model. EBioMedicine. 108. 105325–105325. 6 indexed citations
4.
Finne, Kenneth, et al.. (2024). Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry. Frontiers in Immunology. 15. 1325191–1325191. 10 indexed citations
5.
Finne, Kenneth, Even Birkeland, Ingeborg Winge, et al.. (2023). Hypoxia induced responses are reflected in the stromal proteome of breast cancer. Nature Communications. 14(1). 3724–3724. 10 indexed citations
6.
Milošević, Vladan, Ingeborg Winge, Carina Strell, et al.. (2023). Vessel size as a marker of survival in estrogen receptor positive breast cancer. Breast Cancer Research and Treatment. 200(2). 293–304. 4 indexed citations
7.
Kleppe, Rune, Ingeborg Winge, Tor‐Arne Hegvik, et al.. (2020). GADL1 is a multifunctional decarboxylase with tissue-specific roles in β-alanine and carnosine production. Science Advances. 6(29). eabb3713–eabb3713. 33 indexed citations
8.
Raasakka, Arne, et al.. (2017). Structure of the mouse acidic amino acid decarboxylase GADL1. Acta Crystallographica Section F Structural Biology Communications. 74(1). 65–73. 4 indexed citations
9.
Winge, Ingeborg, Knut Teigen, Rune Kleppe, et al.. (2015). Mammalian CSAD and GADL1 have distinct biochemical properties and patterns of brain expression. Neurochemistry International. 90. 173–184. 24 indexed citations
10.
Johansson, Stefan, et al.. (2013). Functional Properties of Rare Missense Variants of Human CDH13 Found in Adult Attention Deficit/Hyperactivity Disorder (ADHD) Patients. PLoS ONE. 8(8). e71445–e71445. 26 indexed citations
11.
Halmøy, Anne, Stefan Johansson, Ingeborg Winge, et al.. (2010). Attention-Deficit/Hyperactivity Disorder Symptoms in Offspring of Mothers With Impaired Serotonin Production. PubMed. 67(10). 1033–1043. 47 indexed citations
12.
Calvo, Ana Cristina, Tanja Scherer, Ángel L. Pey, et al.. (2010). Effect of pharmacological chaperones on brain tyrosine hydroxylase and tryptophan hydroxylase 2. Journal of Neurochemistry. 114(3). 853–863. 32 indexed citations
13.
McKinney, Jeffrey A., et al.. (2009). Functional properties of missense variants of human tryptophan hydroxylase 2. Human Mutation. 30(5). 787–794. 27 indexed citations
14.
Winge, Ingeborg, Jeffrey A. McKinney, Ming Ying, et al.. (2008). Activation and stabilization of human tryptophan hydroxylase 2 by phosphorylation and 14-3-3 binding. Biochemical Journal. 410(1). 195–204. 56 indexed citations
15.
Winge, Ingeborg, Jeffrey A. McKinney, Per M. Knappskog, & Jan Haavik. (2006). Characterization of wild‐type and mutant forms of human tryptophan hydroxylase 2. Journal of Neurochemistry. 100(6). 1648–1657. 27 indexed citations
16.
Sánchez‐Piris, Maribel, Francesc Posas, Ingeborg Winge, et al.. (2002). The Serine/Threonine Kinase Cmk2 Is Required for Oxidative Stress Response in Fission Yeast. Journal of Biological Chemistry. 277(20). 17722–17727. 51 indexed citations
17.
Winge, Ingeborg & Ian F. Pryme. (2002). SODIUM BUTYRATE STIMULATES THE SYNTHESIS OF FIREFLY LUCIFERASE IN TRANSFECTED CHO CELLS BUT LEVELS OF BiP CHAPERONE ARE UNAFFECTED. Cell Biology International. 26(6). 489–494. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026